Zevra Therapeutics Cash from Investing (TTM) Analysis

Zevra Therapeutics Inc (ZVRA)

4.805 +0.07 (+1.48%) USD | NASDAQ | May 03, 16:00

4.805 0.00 (0.00%) After-Hours: 18:35

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	-17.39M
September 30, 2023	-28.04M
June 30, 2023	16.69M
March 31, 2023	-50.43M
December 31, 2022	-36.72M
September 30, 2022	-52.10M
June 30, 2022	-52.37M
March 31, 2022	-19.37M
December 31, 2021	-15.52M
September 30, 2021	-0.111M
June 30, 2021	-0.107M
March 31, 2021	-0.022M
December 31, 2020	-0.033M
September 30, 2020	-0.012M
June 30, 2020	-0.016M
March 31, 2020	-0.02M
December 31, 2019	3.234M
September 30, 2019	11.20M
June 30, 2019	11.66M

Date	Value
March 31, 2019	27.35M
December 31, 2018	33.33M
September 30, 2018	35.38M
June 30, 2018	40.58M
March 31, 2018	30.94M
December 31, 2017	27.41M
September 30, 2017	23.14M
June 30, 2017	21.10M
March 31, 2017	-25.41M
December 31, 2016	-45.85M
September 30, 2016	-70.63M
June 30, 2016	-74.30M
March 31, 2016	-33.85M
December 31, 2015	-19.14M
September 30, 2015	-0.125M
June 30, 2015	-0.076M
March 31, 2015	-0.064M
December 31, 2014	-0.047M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-52.37M

Minimum

Jun 2022

16.69M

Maximum

Jun 2023

-12.08M

Average

-0.107M

Median

Jun 2021

Cash from Investing (TTM) Benchmarks